1.25

1.63% 0.02

After Hours: 1.24 -0.01 -0.80%

Co Diagnostics Inc (CODX)

Overview News Price History Option Chain Financials Discussions Forecast

Co Diagnostics Inc stock is traded at $1.25, with a volume of 64,918. It is up +1.63% in the last 24 hours and down -10.07% over the past month. Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Previous Close:

$1.23

Open:

$1.21

24h Volume:

64,918

Relative Volume:

0.27

Market Cap:

$38.77M

Revenue:

$4.66M

Net Income/Loss:

$-42.56M

P/E Ratio:

-1.0081

EPS:

-1.24

Net Cash Flow:

$-22.51M

1W Performance:

+3.31%

1M Performance:

-10.07%

6M Performance:

+11.61%

1Y Performance:

+17.92%

1-Day Range:

$1.15

$1.2899

1-Week Range:

$1.14

$1.2899

52-Week Range:

$0.9811

$2.2299

Co Diagnostics Inc Stock (CODX) Company Profile

Name

Co Diagnostics Inc

Sector

Healthcare (1190)

Industry

Medical Devices (154)

Phone

(801) 278-9769

Address

4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY

Employee

155

Twitter

@Co_Diagnostics

Next Earnings Date

2024-08-08

Latest SEC Filings

CODX's Discussions on Twitter

Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-12-22	Downgrade	Sidoti	Buy → Neutral
Dec-29-21	Initiated	Sidoti	Buy
Mar-29-21	Downgrade	Maxim Group	Buy → Hold
May-20-20	Upgrade	Maxim Group	Hold → Buy
May-18-20	Reiterated	H.C. Wainwright	Buy
Mar-09-20	Reiterated	H.C. Wainwright	Buy
Mar-03-20	Downgrade	Maxim Group	Buy → Hold

View All

Co Diagnostics Inc Stock (CODX) Latest News

Sep 27, 2024

Co-Diagnostics, Inc. (NASDAQ:CODX) Short Interest Down 30.9% in September - Defense World

Sep 27, 2024

Sep 24, 2024

Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan - StockTitan

Sep 24, 2024

Sep 06, 2024

Co-Diagnostics Inc Inc. (CODX) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle

Sep 06, 2024

Sep 05, 2024

Co-Diagnostics' Mpox test effective against new clade - Investing.com

Sep 05, 2024

Co-Diagnostics completes updated clade Ib analysis of 2-Gene Mpox RUO test - TipRanks

Sep 05, 2024

Co-Diagnostics' Mpox test effective against new clade - Investing.com India

Sep 05, 2024

Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test - PR Newswire

Sep 05, 2024

Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO Test - StockTitan

Sep 05, 2024

Sep 02, 2024

How does Co-Diagnostics Inc (CODX) change from a tortoise to a hare? - SETE News

Sep 02, 2024

Balance Sheet Insights: Co-Diagnostics Inc (CODX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Sep 02, 2024